0001104659-21-095084.txt : 20210722
0001104659-21-095084.hdr.sgml : 20210722
20210722210105
ACCESSION NUMBER: 0001104659-21-095084
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210720
FILED AS OF DATE: 20210722
DATE AS OF CHANGE: 20210722
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Esposito Pamela
CENTRAL INDEX KEY: 0001744425
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38596
FILM NUMBER: 211108866
MAIL ADDRESS:
STREET 1: C/O REPLIMUNE GROUP, INC.
STREET 2: 18 COMMERCE WAY
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Replimune Group, Inc.
CENTRAL INDEX KEY: 0001737953
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 822082553
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 500 UNICORN PARK
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: (781) 222-9600
MAIL ADDRESS:
STREET 1: 500 UNICORN PARK
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
tm2123078-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-07-20
0
0001737953
Replimune Group, Inc.
REPL
0001744425
Esposito Pamela
C/O REPLIMUNE GROUP, INC.,
500 UNICORN PARK
WOBURN
MA
01801
0
1
0
0
Chief Business Officer
Common Stock
2021-07-20
4
M
0
4862
1.01
A
215021
D
Common Stock
2021-07-20
4
S
0
4862
33.05
D
210159
D
Common Stock
2021-07-21
4
M
0
12538
1.01
A
222697
D
Common Stock
2021-07-21
4
S
0
12538
33.17
D
210159
D
Employee Stock Option (right to buy)
1.01
2021-07-20
4
M
0
4862
0
D
2025-11-01
Common Stock
4862
63741
D
Employee Stock Option (right to buy)
1.01
2021-07-21
4
M
0
12538
0
D
2025-11-01
Common Stock
12538
51203
D
The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
Following the sales reported on this Form 4, the reporting person continues to beneficially own 210,159 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 488,102 shares of the Issuer's common stock, 324,649 of which are exercisable as of the date hereof. Due to scrivener's error, footnote 2 of the Form 4 filed on behalf of the reporting person on July 19, 2021 inadvertently overstated the number of options held by the Reporting Person following the transaction reported therein. The amounts stated in this footnote 2 set forth the correct number of options held by the Reporting Person following the transaction reported herein.
The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof.
/s/ Jean Franchi, attorney-in-fact
2021-07-22